According to Zhitong Financial App, Huayang Xincai (600281.SH) released the 2023 semi-annual report. During the reporting period, the company achieved operating income of 193 million yuan, an increase of 4.94% over the previous year; net loss attributable to shareholders of listed companies was 91.6634 million yuan, from profit to loss; net loss attributable to shareholders of listed companies deducted from non-recurring profit and loss of 91,8241 million yuan, from profit to loss; basic loss per share was 0.1,782 yuan/share.
During the reporting period, in order to promote the company's transformation and development, the company acquired 100% of the shares in the biotechnology company owned by Shanxi Huaxu Logistics Co., Ltd., a subsidiary of Taihua Group. In this transaction, Taihua Group is the controlling shareholder of the company, and the biotechnology company and the company are enterprises under the same control. In April 2023, the company completed matters relating to the registration of equity changes in biotechnology companies, which have been included in the scope of the company's consolidated statements since April 2023. Since the company and the biotech company were controlled by Taihua Group before and after the merger, and that control was not temporary, the merger was a merger of companies under the same control.